Showing 1 - 10 results of 10 for search 'Zipp F', query time: 0.03s
Refine Results
-
1
Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status. by Jarius, S, Paul, F, Franciotta, D, Aktas, O, Hohlfeld, R, Zipp, F, Vincent, A
Published 2007Journal article -
2
Role of extracellular signal-related kinase (Erk) 1 in the regulation of neuroinflammation by Waiczies S, Zipp F, Loddenkemper C, Schulze-Topphoff U, Siffrin V, Leuenberger T, Pfueller CF, Bendix I
Published 2009-02-01Article -
3
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. by Jarius, S, Paul, F, Franciotta, D, Waters, P, Zipp, F, Hohlfeld, R, Vincent, A, Wildemann, B
Published 2008Journal article -
4
-
5
-
6
Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis by Jarius, S, Paul, F, da Silva, A, Leite, M, Waters, P, Littleton, E, Franciotta, D, Palace, J, Zipp, F, Vincent, A
Published 2007Conference item -
7
Neuroprotection and enhanced neurogenesis by extract from the tropical plant <it>Knema laurina </it>after inflammatory damage in living brain tissue by Zipp F, Latiff A, Said I, Din L bin, Ismail G, Reymann K, Paulsen-Merker K, Neumann J, Schönenberger S, Häke I, Ullrich O
Published 2009-02-01Article -
8
Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. by Paul, F, Jarius, S, Aktas, O, Bluthner, M, Bauer, O, Appelhans, H, Franciotta, D, Bergamaschi, R, Littleton, E, Palace, J, Seelig, H, Hohlfeld, R, Vincent, A, Zipp, F
Published 2007Journal article -
9
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. by Sawcer, S, Hellenthal, G, Pirinen, M, Spencer, C, Patsopoulos, N, Moutsianas, L, Dilthey, A, Su, Z, Freeman, C, Hunt, SE, Edkins, S, Gray, E, Booth, DR, Potter, S, Goris, A, Band, G, Oturai, AB, Strange, A, Saarela, J, Bellenguez, C, Fontaine, B, Gillman, M, Hemmer, B, Gwilliam, R, Zipp, F
Published 2011Journal article -
10
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. by Beecham, A, Patsopoulos, N, Xifara, D, Davis, M, Kemppinen, A, Cotsapas, C, Shah, T, Spencer, C, Booth, D, Goris, A, Oturai, A, Saarela, J, Fontaine, B, Hemmer, B, Martin, C, Zipp, F, D'Alfonso, S, Martinelli-Boneschi, F, Taylor, B, Harbo, H, Kockum, I, Hillert, J, Olsson, T, Ban, M, Oksenberg, JR
Published 2013Journal article